# Peptides Studied for Sexual Dysfunction: The Trials

Source: https://pepvault.app/conditions/sexual-dysfunction

Last updated: 2026-11-19

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [By condition](https://pepvault.app/conditions) Sexual Dysfunction

Peptides by condition · Hormones and sexual health

# Peptides studied for low sexual desire and erectile dysfunction

Checked November 2026 against our study pages and the FDA labels [Published by PepVault](https://pepvault.app/guides/how-we-research)

Our library holds 7 study pages on low sexual desire and erectile dysfunction: 7 in people (4 of them meta-analyses or randomized trials). They studied 2 compounds, with this many study pages each: PT-141 5 and Melanotan II 2.

## What the research on low sexual desire and erectile dysfunction looks like

Two sexual problems have peptide research in people: low sexual desire that causes distress in women, called hypoactive sexual desire disorder (HSDD), and erectile dysfunction in men. The peptides studied act on melanocortin receptors in the brain, which sets them apart from the erection pills that act on blood flow.

The desire trials asked women to log satisfying sexual events and rate desire on questionnaires, against placebo. The erection studies tracked erections over several hours with RigiScan, a device that records their firmness.

Side effects matter as much as benefit here: nausea and flushing were common, and some people stopped because of them. The erection studies were small and early, with a handful of men each.

How many of the 7 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## The 7 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

1. ### [PT-141](https://pepvault.app/peptides/pt-141)

   5 in people

   For low sexual desire and erectile dysfunction, 5 of our study pages are filed under PT-141: 1 meta-analysis, 3 randomized trials and 1 systematic review in people. The largest in people pooled 3,500 people and was published in 2022. They were published from 2016 to 2022, in J Sex Res, J Womens Health (Larchmt), Womens Health (Lond) and J Sex Med.

   FDA-approved, with a use tied to low sexual desire and erectile dysfunction on its label: Vyleesi (injection) for low sexual desire that causes marked distress (acquired, generalized hypoactive sexual desire disorder) in premenopausal women; its label says it is not for men or to enhance sexual performance.

   - Meta-analysis in people · 2021 [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
   - Randomized trial in people · 1,202 people · 2022 [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
   - Randomized trial in people · 327 people · 2016 [PT-141: +0.7 vs +0.2 satisfying sexual events a month at 12 weeks](https://pepvault.app/research/pt-141-clayton-2016)
   - Randomized trial in people · 2019 [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
   - Systematic review in people · 3,500 people · 2022 [PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data](https://pepvault.app/research/pt-141-clayton-2022)

   - [Vyleesi, from its FDA label](https://pepvault.app/drugs/vyleesi)
   - [PT-141: legal and regulatory status](https://pepvault.app/peptides/pt-141/legal-status)
   - [PT-141 in the library](https://pepvault.app/peptides/pt-141)
   - [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)
2. ### [Melanotan II](https://pepvault.app/peptides/melanotan-ii)

   2 in people

   For low sexual desire and erectile dysfunction, 2 of our study pages are filed under Melanotan II: 2 clinical trials in people. The largest in people enrolled 20 people and was published in 2000. They were published from 1998 to 2000, in Int J Impot Res and J Urol.

   Melanotan II has no FDA-approved product: Drugs@FDA lists no application for it.

   - Clinical trial in people · 20 people · 2000 [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000)
   - Clinical trial in people · 10 people · 1998 [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998)

   - [Melanotan II: legal and regulatory status](https://pepvault.app/peptides/melanotan-ii/legal-status)
   - [Melanotan II in the library](https://pepvault.app/peptides/melanotan-ii)
   - [Melanotan II dose guide](https://pepvault.app/lab/dosage/melanotan-ii)

## On low sexual desire and erectile dysfunction

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Melanotan II

- [Melanotan II: the full reference](https://pepvault.app/peptides/melanotan-ii)
- [Melanotan II dose guide](https://pepvault.app/lab/dosage/melanotan-ii)

### Mixing charts

- [PT-141 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)
- [Melanotan II 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/melanotan-ii-5mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
- [All 6 studies](https://pepvault.app/research#pt-141)
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000)
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998)
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996)
- [All 5 studies](https://pepvault.app/research#melanotan-ii)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan I vs Melanotan II](https://pepvault.app/peptides/compare/melanotan-i-vs-melanotan-ii)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Related conditions

- [Peptides studied for cancer](https://pepvault.app/conditions/cancer)
- [Peptides studied for low testosterone (hypogonadism)](https://pepvault.app/conditions/hypogonadism)
- [Peptides studied for polycystic ovary syndrome (PCOS)](https://pepvault.app/conditions/pcos)
- [Peptides studied for growth hormone deficiency](https://pepvault.app/conditions/growth-hormone-deficiency)

### By goal

- [Peptides for libido and sexual health](https://pepvault.app/peptides/for/libido)
- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)

## Side by side

For the 2 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

| Compound | In people | Animals or cells | Largest in people | FDA |
| --- | --- | --- | --- | --- |
| [PT-141](https://pepvault.app/peptides/pt-141) | 5 | 0 | 3,500 | Approved, a use tied to it |
| [Melanotan II](https://pepvault.app/peptides/melanotan-ii) | 2 | 0 | 20 | Not approved |

## What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021) This is one author's re-analysis of two existing trials, not a new trial. Treating trial completion plus joining the follow-up study as a preference for placebo is an indirect measure.
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022) This splits two trials into smaller subgroups, and a few subgroups, including desire in hormonal birth control users, did not reach a significant result. It covers the 24-week controlled phase, not the longer open-label extension.
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000) This was a small trial of 20 men, with each response measured over only 6 h after dosing. It doesn't show what happens with repeated or long-term use, or how safe that would be.
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998) This was a very small trial in only 10 men, with each response measured over a single 6-hour window. It included only men without a physical cause for their erectile dysfunction, so it doesn't show results in other groups or with longer use.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

## Related pages

- [Peptides studied for cancer 1 compound in common](https://pepvault.app/conditions/cancer)
- [Peptides studied for low testosterone (hypogonadism) 15 studies](https://pepvault.app/conditions/hypogonadism)
- [Peptides studied for polycystic ovary syndrome (PCOS) 4 studies](https://pepvault.app/conditions/pcos)
- [Peptides studied for growth hormone deficiency 7 studies](https://pepvault.app/conditions/growth-hormone-deficiency)

### By goal

- [Peptides for libido and sexual health](https://pepvault.app/peptides/for/libido)
- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)

### Trial terms

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Phase 1, 2 and 3 trials](https://pepvault.app/glossary/clinical-trial-phases)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## Questions

### Which peptides have been studied for low sexual desire and erectile dysfunction?

Our 7 study pages on low sexual desire and erectile dysfunction are filed under 2 compounds, with this many each: PT-141 5 and Melanotan II 2. PT-141 has the most.

### Have any been tested in people with low sexual desire and erectile dysfunction?

Yes: all 7 were in people, 4 of them meta-analyses or randomized trials (PT-141). The largest pooled 3,500 people: “PT-141: nausea in 40.0% vs 1.3% on placebo in phase 3 safety data” (2022).

### Is any peptide FDA-approved for low sexual desire and erectile dysfunction?

Yes, with a use tied to low sexual desire and erectile dysfunction on their FDA labels: PT-141 as Vyleesi. 1 other compound here with an FDA record has no use tied to it.

### How large were the studies in people on low sexual desire and erectile dysfunction?

Of the 7 in people, 5 give their size on our pages: 2 had 1,000 people or more, 1 had 100 to 999 and 2 had fewer than 100. The largest, a systematic review from 2022, pooled 3,500.

### What is the newest study on low sexual desire and erectile dysfunction here?

Of our study pages on low sexual desire and erectile dysfunction, the newest is “PT-141: desire gains over placebo held across RECONNECT subgroups”, a randomized trial in people published in 2022.

## How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## On low sexual desire and erectile dysfunction

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Melanotan II

- [Melanotan II: the full reference](https://pepvault.app/peptides/melanotan-ii)
- [Melanotan II dose guide](https://pepvault.app/lab/dosage/melanotan-ii)

### Mixing charts

- [PT-141 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)
- [Melanotan II 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/melanotan-ii-5mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
- [All 6 studies](https://pepvault.app/research#pt-141)
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000)
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998)
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996)
- [All 5 studies](https://pepvault.app/research#melanotan-ii)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan I vs Melanotan II](https://pepvault.app/peptides/compare/melanotan-i-vs-melanotan-ii)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Related conditions

- [Peptides studied for cancer](https://pepvault.app/conditions/cancer)
- [Peptides studied for low testosterone (hypogonadism)](https://pepvault.app/conditions/hypogonadism)
- [Peptides studied for polycystic ovary syndrome (PCOS)](https://pepvault.app/conditions/pcos)
- [Peptides studied for growth hormone deficiency](https://pepvault.app/conditions/growth-hormone-deficiency)

### By goal

- [Peptides for libido and sexual health](https://pepvault.app/peptides/for/libido)
- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## By condition

- [Every condition](https://pepvault.app/conditions)
- [Peptides studied for cancer](https://pepvault.app/conditions/cancer)
- [Peptides studied for low testosterone (hypogonadism)](https://pepvault.app/conditions/hypogonadism)
- [Peptides studied for polycystic ovary syndrome (PCOS)](https://pepvault.app/conditions/pcos)
- [Peptides studied for growth hormone deficiency](https://pepvault.app/conditions/growth-hormone-deficiency)

## The research

- [Studies, in plain English](https://pepvault.app/research)
- [The peptide reference library](https://pepvault.app/peptides)
- [Peptides by goal](https://pepvault.app/peptides/for)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
